白云山(00874.HK)子公司拟斥5亿元收购浙江省医药流通企业

Core Viewpoint - The company Baiyunshan (00874.HK) has announced a share acquisition agreement with an independent third party, Haizheng Pharmaceutical, for the purchase of 100% equity in the target company, Zhejiang Yigong, for approximately RMB 500 million [1] Group 1 - The buyer, a subsidiary of the company, Guangzhou Pharmaceutical, will acquire 100% equity of the target company upon completion of the transaction [1] - The target company, Zhejiang Yigong, is a pharmaceutical distribution enterprise based in Zhejiang Province, primarily engaged in the wholesale of various pharmaceutical products [1]